Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score67
United States Fiscal year ends December CIK 0001088856 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Gary Charles Robb
17 Aug 2026
Chief Business Officer
Sell indirect
10,000
$116.26
$1.16M
Joseph Douglas Lyon
3 Aug 2026
See Remarks
Sell
1,540
$114.16
$175.81K
David L Mahoney
17 Jun 2026
Director
Sell indirect
20,000
$84.53
$1.69M
Joseph Douglas Lyon
27 May 2026
See Remarks
Sell
5,000
$65.00
$325.00K
William Guyer
25 Nov 2025
Chief Development Officer
Sell
4,500
$80.90
$364.07K

What was left out

Form 4 filings counted 99
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 77
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 5,647,551
History held since 3 Oct 2006